United States · Bill · HR
H.R. 2241 (110th)
Diabetes Treatment and Prevention Act of 2007
Introduced
9 May 2007
Last action
9 May 2007 · Introduced
Status
Referred to the Subcommittee on Health.
Sponsors
ELIOT ENGEL, Rep. Fossella, Vito [R-NY-13], GENE GREEN, Diana DeGette, Rep. Towns, Edolphus [D-NY-11], Rep. Allen, Thomas H. [D-ME-1], Rep. Pastor, Ed [D-AZ-7], Rep. Gordon, Bart [D-TN-6], Rep. Carson, André [D-IN-7], Rep. Abercrombie, Neil [D-HI-1]
Subjects
Healthcare, Education
Source updated
14 August 2025
Summary
Diabetes Treatment and Prevention Act of 2007 - Amends the Public Health Service Act to require the Director of the Centers for Disease Control and Prevention (CDC) to establish the Division of Diabetes Translation to eliminate diabetes. Requires the Director to develop pilot demonstration projects to evaluate various approaches to: (1) screening and identifying persons with pre-diabetes and undiagnosed diabetes; and (2) providing such persons with access to appropriate lifestyle interventions. Requires such projects to be carried out with the goal of translating the Diabetes Prevention Program clinical trial into interventions to reduce the incidence of type-2 diabetes and its related complications in the U.S. population. Requires the Secretary of Health and Human Services, acting through the Director, to engage in partnerships with state and local health departments to carry out: (1) national, state, and local surveillance related to diabetes; and (2) education and information campaigns to increase awareness about the importance of primary prevention, ways to assess personal risk, and how to locate and access diabetes prevention programs. Requires the Director, acting through the Division, to develop a pilot program to improve treatment for individuals with diabetes and other co-occurring chronic conditions for which treatment may complicate the treatment for diabetes. Requires the Director to give preference to research that: (1) focuses on conditions which have a high prevalence among individuals with diabetes or for which the treatment involved has the potential to impact adherence to diabetes treatment regiments; and (2) builds upon existing work designed to improve the quality of care for patients with diabetes.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
9 May 2007
Referred
Referred to the Subcommittee on Health.
Source: Committee
9 May 2007
Introduced
Referred to the House Committee on Energy and Commerce.
Source: IntroReferral
9 May 2007
Introduced
Sponsor introductory remarks on measure. (CR E1000)
Source: IntroReferral
9 May 2007
Introduced
Introduced in House
Source: IntroReferral
9 May 2007
Introduced
Introduced in House
Source: IntroReferral
Votes
No vote records are attached yet.
Versions
- Introduced in House · 9 May 2007 · Official file
Documents
3 official files
Introduced in House (text)
Introduced in House (text)
Introduced in House · EN · 9 May 2007
Introduced in House (PDF)
Introduced in House · EN · 9 May 2007
Introduced in House
summary · EN · 9 May 2007
Sponsors
- ELIOT ENGEL · D · Sponsor
- Rep. Fossella, Vito [R-NY-13] · R · Sponsor
- GENE GREEN · D · Sponsor
- Diana DeGette · D · Sponsor
- Rep. Towns, Edolphus [D-NY-11] · D · Cosponsor
- Rep. Allen, Thomas H. [D-ME-1] · D · Cosponsor
- Rep. Pastor, Ed [D-AZ-7] · D · Cosponsor
- Rep. Gordon, Bart [D-TN-6] · D · Cosponsor
- Rep. Carson, André [D-IN-7] · D · Cosponsor
- Rep. Abercrombie, Neil [D-HI-1] · D · Cosponsor
- · hsif00 · Standing
Related records
- related to ← Diabetes Treatment and Prevention Act of 2007
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/110th-congress/house-bill/2241
- Open data entity: https://api.congress.gov/v3/bill/110/hr/2241
- us · 110-hr-2241 · source updated 14 August 2025